Chaosu Hu

Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial

Yunpeng Yang, Song Qu, Jingao Li et al. · The Lancet Oncology · 2021 · 449 citations

Medicine, Oncology, Pharmacology +12

The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma

Ling‐Long Tang, Yu‐Pei Chen, Chuanben Chen et al. · Cancer Communications · 2021 · 401 citations · Full text

Medicine, Oncology, Surgery +13

Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma

Hai‐Qiang Mai, Qiuyan Chen, Dongping Chen et al. · JAMA · 2023 · 233 citations · Full text

Medicine, Oncology, Pharmacology +15

Tislelizumab plus chemotherapy as first-line treatment for recurrent or metastatic nasopharyngeal cancer: A multicenter phase 3 trial (RATIONALE-309)

Yunpeng Yang, Jianji Pan, Hui Wang et al. · Cancer Cell · 2023 · 215 citations · Full text

Medicine, Oncology, Pharmacology +17

The impact of training sample size on deep learning-based organ auto-segmentation for head-and-neck patients

Yingtao Fang, Jiazhou Wang, Xiaomin Ou et al. · Physics in Medicine and Biology · 2021 · 78 citations · Full text

Computing, Oncology, Radiation Oncology +17